Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Allakos Inc. ALLK

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. In preclinical and clinical studies, AK002 has been shown to deplete eosinophils and inhibit mast cells.


Recent & Breaking News (NDAQ:ALLK)

SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA March 26, 2020

ALLK CLASS ACTION DEADLINE: Bernstein Liebhard Announces that a Securities Class Action Lawsuit has been Filed Against Allakos Inc.

PR Newswire March 26, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Allakos (ALLK) Investors with Losses to Contact Its Attorneys: Application Deadline Approaching

GlobeNewswire March 25, 2020

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against World Wrestling Entertainment, NMC Health, Funko, and Allakos and Encourages Investors to Contact the Firm

GlobeNewswire March 25, 2020

ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Announces that a Securities Class Action Lawsuit has been Filed Against Allakos Inc.

Business Wire March 25, 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA March 25, 2020

WWE & ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Notifies Investors of Class Actions and Encourages Investors to Contact the Firm

ACCESSWIRE IA March 25, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK

GlobeNewswire March 24, 2020

Allakos Announces the Initiation of Antolimab (AK002) Clinical Studies

GlobeNewswire March 24, 2020

Allakos Announces Positive Phase 1 Results with Antolimab (AK002) in Mast Cell Gastrointestinal Disease

GlobeNewswire March 24, 2020

Allakos Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm

Newsfile March 24, 2020

ALLK ALERT: ROSEN, A LEADING FIRM, Reminds Allakos Inc. Investors of Important May 11th Deadline in Securities Class Action First Filed By Firm- ALLK

ACCESSWIRE IA March 23, 2020

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA March 21, 2020

ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Allakos Inc. Investors of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire March 20, 2020

ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Allakos Inc. Investors of Class Action and Encourages Investors with Losses in Exceeding $100,000 to Contact the Firm

ACCESSWIRE IA March 20, 2020

Allakos Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm

Newsfile March 20, 2020

ALLK SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Alerts Allakos Inc. Investors of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire March 19, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Allakos (ALLK) Investors with Losses to Contact Its Attorneys: Application Deadline Approaching

GlobeNewswire March 18, 2020

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Funko, Allakos, and Cronos Group and Encourages Investors to Contact the Firm

GlobeNewswire March 18, 2020

SHAREHOLDER DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA March 18, 2020